- The paper establishes that 2PPT microscopy achieves label-free imaging of metabolic coenzymes NADH and FAD with detection limits of 0.87 μM and 0.99 μM.
- It details a synchronized NIR pump and visible probe methodology that enhances the signal-to-background ratio and spatial resolution over conventional techniques.
- Results reveal distinct mitochondrial morphological and metabolic responses in ovarian cancer cells and 3D spheroids under chemotherapy and metabolic stress.
Introduction
The paper presents two-photon photothermal (2PPT) microscopy as a novel, label-free optical imaging modality for quantifying metabolic coenzymes NADH and FAD with sub-micromolar sensitivity. This approach addresses inherent limitations of autofluorescence-based techniques, such as low quantum yield and spectral overlap, by exploiting local heat generation via two-photon absorption in chromophores. The study provides detailed characterization of 2PPT’s photothermal signal generation mechanism and demonstrates enhanced sensitivity and specificity in capturing mitochondrial metabolic activity, including robust detection during chemotherapy-induced perturbations.
Methodological Advancements in 2PPT Microscopy
2PPT microscopy is implemented through synchronized near-infrared (NIR) pump and visible probe beams, modulated via acousto-optic modulation to optimize transient heat generation and signal extraction. The detection relies on lock-in amplifier demodulation of the probe beam’s intensity changes induced by localized thermal lensing effects. Sub-micromolar detection limits (LOD) for NADH (0.87 μM) and FAD (0.99 μM) are achieved, representing a sensitivity boost of up to 20-fold and 10-fold, respectively, over conventional two-photon autofluorescence (2PAF) modalities.
The study rigorously compares 2PPT and 2PAF in mapping NADH/FAD distribution in SK-OV-3 ovarian cancer cells. 2PPT delivers improved signal-to-background ratio (SBR, 14.27 dB vs. 3.36 dB for 2PAF), enabling clear visualization of mitochondrial morphology, including differentiation between tubular (healthy, energy-producing) and oval (stress-associated, dysfunctional) structures. Photothermal spectral analysis indicates that mitochondrial contrast in living cells primarily originates from metabolic cofactors rather than heme proteins, allowing discrimination based on pump wavelength and spectral features.
2PPT robustly detects metabolic perturbations in cancer cells at single-organelle resolution. Upon N-acetylcysteine (NAC) treatment, a ROS inhibitor, both NADH and FAD levels are significantly reduced, with corresponding alterations in mitochondrial morphology, shifting toward oval shapes. Starvation experiments reveal adaptive, time-dependent mitochondrial metabolic responses: tubular mitochondria show transient NADH increases after 24 hours of starvation, followed by subsequent decline, while oval mitochondria consistently exhibit decreased metabolic activity under stress.
Spheroid Imaging and Chemotherapeutic Response
Extending 2PPT imaging to ovarian cancer spheroids, the modality enables volumetric metabolic mapping within physiologically relevant 3D constructs. Cisplatin chemotherapy induces a marked reduction in NADH signal and a concomitant increase in FAD signal across cell populations within spheroids, reflecting metabolic reprogramming toward an oxidative phenotype. These findings confirm that 2PPT captures spatial heterogeneity and dynamic metabolic shifts not easily attainable by fluorescence-based modalities, especially in scattering, high-density systems.
Numerical Results and Contradictory Claims
- LOD for NADH (0.87 μM) and FAD (0.99 μM) exceed autofluorescence sensitivity by factors of 20 and 10, respectively.
- SBR improvement for mitochondrial imaging is over fourfold relative to 2PAF.
The claim that 2PPT achieves order-of-magnitude better sensitivity, without exogenous probes, contradicts prevailing assumptions regarding the superiority of fluorescence-based methods for intrinsic chromophore detection.
Practical and Theoretical Implications
2PPT enables quantitative, label-free metabolic mapping with sub-organelle spatial resolution and sub-micromolar concentration sensitivity. Practically, this supports the rapid and unbiased assessment of cellular metabolic adaptation during therapeutic intervention and environmental stress, potentially informing biomarker-driven oncologic diagnostics. Theoretically, photothermal detection uncouples metabolic imaging from quantum yield limitations and spectral crosstalk, paving the way for quantitative, multiplexed imaging of metabolic flux in complex biological systems.
These findings suggest that future metabolic imaging platforms will integrate absorption and photothermal contrasts with multiphoton excitation to achieve both sensitivity and depth penetration. 2PPT's compatibility with 3D, scattering tissues and ability to probe heterogeneous metabolic niches in spheroidal and organoid models highlight its translation potential to in vivo contexts. Future developments may combine 2PPT with complementary photoacoustic, FLIM, or polarization ratiometric methods for holistic characterization of cellular energetics and redox states.
Conclusion
2PPT microscopy establishes a new standard for label-free metabolic imaging, delivering sub-micromolar quantification of NADH and FAD with enhanced molecular specificity and spatial resolution. The methodology reveals functional and morphological mitochondrial heterogeneity in cancer cells and spheroids under metabolic perturbation and chemotherapy, supporting its role as a sensitive probe of cellular bioenergetics. Extension and integration with other optical platforms will accelerate its adoption in translational metabolic and oncologic research.